全文获取类型
收费全文 | 1264篇 |
免费 | 132篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 34篇 |
妇产科学 | 15篇 |
基础医学 | 177篇 |
口腔科学 | 40篇 |
临床医学 | 69篇 |
内科学 | 395篇 |
皮肤病学 | 127篇 |
神经病学 | 57篇 |
特种医学 | 49篇 |
外科学 | 114篇 |
综合类 | 13篇 |
预防医学 | 63篇 |
眼科学 | 16篇 |
药学 | 48篇 |
肿瘤学 | 188篇 |
出版年
2024年 | 5篇 |
2023年 | 14篇 |
2022年 | 22篇 |
2021年 | 20篇 |
2020年 | 17篇 |
2019年 | 22篇 |
2018年 | 45篇 |
2017年 | 58篇 |
2016年 | 49篇 |
2015年 | 55篇 |
2014年 | 55篇 |
2013年 | 48篇 |
2012年 | 90篇 |
2011年 | 102篇 |
2010年 | 54篇 |
2009年 | 38篇 |
2008年 | 64篇 |
2007年 | 77篇 |
2006年 | 88篇 |
2005年 | 93篇 |
2004年 | 67篇 |
2003年 | 75篇 |
2002年 | 72篇 |
2001年 | 12篇 |
2000年 | 9篇 |
1999年 | 16篇 |
1998年 | 15篇 |
1997年 | 8篇 |
1996年 | 6篇 |
1995年 | 8篇 |
1994年 | 10篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 3篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1969年 | 6篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1957年 | 1篇 |
排序方式: 共有1417条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon‐free therapy in hepatitis C virus genotype 1b 下载免费PDF全文
Kazuhiko Hayashi Masatoshi Ishigami Yoji Ishizu Teiji Kuzuya Takashi Honda Hiroki Kawashima Tetsuya Ishikawa Yoshihiko Tachi Masashi Hattori Yoshiaki Katano Hidemi Goto Yoshiki Hirooka 《Journal of gastroenterology and hepatology》2018,33(1):249-255
Background and Aim
Virologic failure of interferon‐free therapy has been associated with Y93H mutation in the non‐structure 5A region in hepatitis C virus (HCV) genotype 1b, and screening is recommended. A simple assay based on Q‐Invader technology was developed for Y93H mutant screening to reduce cost and effort. The present study sought to compare two methods of detection of Y93H mutation and to evaluate the effect of Y93H mutation on response to interferon‐free therapy.Methods
Y93H mutation was examined in 258 patients with HCV genotype 1b using both direct sequencing analysis and the polymerase chain reaction (PCR)‐Invader assay. Daclatasvir and asunaprevir or ledipasvir and sofosbuvir therapy was administered to 205 patients whose sustained virological responses (SVR) were checked.Results
Hepatitis C virus was detected in 232 of 258 patients by direct sequencing and in 236 of 258 patients by the PCR‐Invader assay. Forty of 231 cases were defined as Y93 mutation by direct sequencing, and 46 of 236 cases were defined as Y93 mutation by the PCR‐Invader assay. SVR of patients who were Y93H by direct sequencing, Y93H by the PCR‐Invader assay, and Y93H by both methods was 62.5%, 82.4%, and 50%, respectively.Conclusions
The sensitivity of the PCR‐Invader assay was similar to that of direct sequencing analysis; however, the PCR‐Invader assay had a better ability to detect minor strains. Combination of the two assays would improve prediction of the response to daclatasvir and asunaprevir, but Y93H mutation had little effect on SVR in ledipasvir and sofosbuvir therapy. 相似文献55.
Atsushi Hata Takahiro Nakajima Keisuke Matsusaka Masaki Fukuyo Junichi Morimoto Takayoshi Yamamoto Yuichi Sakairi Bahityar Rahmutulla Satoshi Ota Hironobu Wada Hidemi Suzuki Hisahiro Matsubara Ichiro Yoshino Atsushi Kaneda 《International journal of cancer. Journal international du cancer》2020,146(2):388-399
56.
57.
Masahiro Tajika Keitaro Matsuo Hidemi Ito Dai Chihara Vikram Bhatia Shinya Kondo Tsutomu Tanaka Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Kazuya Matsumoto Tsuneya Nakamura Yasushi Yatabe Kenji Yamao Yasumasa Niwa 《Journal of gastroenterology》2014,49(5):843-852
Background
It is controversial whether patients with gastric marginal zone lymphomas of mucosa associated lymphoid tissue (MALT) have higher risk of second malignancies. The aim of this study was to define the risk of second malignancies in these patients.Methods
We analyzed prospective follow-up data of 146 consecutive patients with gastric MALT lymphoma treated at Aichi Cancer Center Hospital and compared the incidence of second malignancies with that in the general population. We calculated the standardized incidence ratio (SIR), using age- and sex-specific incidence rates from the Aichi Cancer Registry.Results
The median follow-up period was 74 months. A total of 27 tumors occurred in 22 patients (15.1 %), including 19 solid tumors. Of these, nine tumors were detected concomitantly with, and 18 tumors following, the diagnosis of gastric MALT lymphoma. Four patients had two second malignancies each. For the entire group, the SIR of an additional malignancy was 3.39 (95 % confidence interval [CI] 2.11–4.66). An increased incidence of solid tumors (SIR 2.91 [1.60–4.22]) and hematologic malignancies (SIR 5.54 [1.70–9.38]) were seen. In addition, there was increased risk for development of second malignancies during follow up (SIR 2.26 [1.21–3.30]). Chemotherapy for treatment of MALT was an independent risk factor for second malignancies (age–sex adjusted hazard ratio 3.98 [1.47–10.79].Conclusions
Compared with the general population, patients with gastric MALT lymphoma are at increased risk for second malignancies, including gastric cancer. 相似文献58.
Ito-Habe N Wada H Matsumoto T Ohishi K Toyoda H Ishikawa E Nomura S Komada Y Ito M Nobori T Katayama N 《International journal of hematology》2011,93(1):47-52
Thrombotic microangiopathy (TMA) is associated with vascular endothelial cell injury and is sometimes linked with poor outcome. Von Willebrand factor (VWF) propeptide (VWFpp) is considered to be a marker of vascular endothelial cell injury. The plasma levels of VWF, VWFpp, and thrombomodulin (TM) were evaluated for their use in the diagnosis of TMA in 75 patients with TMA. There were 30 TMA patients with marked decreases in ADAMTS13 (TMA/ADAMTS13) and 45 without the decrease (TMA/other). The plasma levels of TM, VWF, and VWFpp values were significantly high in patients with TMA, especially TMA/other group. The plasma levels of TM and VWFpp were significantly high in non-survivor with TMA. In the TMA/other group, the plasma levels of VWFpp were negatively correlated with ADAMTS13 activity. The plasma levels of TM correlated with the renal function, but the plasma levels of VWFpp did not. A ROC analysis indicated that VWFpp and TM were useful markers for the prediction of a poor outcome. These findings suggest that VWFpp is an useful marker for the diagnosis of TMA and for the prediction of poor outcome. 相似文献
59.
60.
Hayashi K Katano Y Takeda Y Honda T Ishigami M Itoh A Hirooka Y Nakano I Yano M Goto H Yoshioka K Toyoda H Kumada T 《Journal of medical virology》2007,79(4):366-373
Hepatitis B virus (HBV) has been classified into eight genotypes and can be further divided into several subgenotypes that have different geographic distributions. Because of increased human migration, the prevalence of rare subgenotypes is increasing in Japanese patients with acute hepatitis B. Lamivudine-resistant strains of HBV have begun to emerge in association with chronic hepatitis B. The aim of this study was to investigate the distribution of HBV subgenotypes and lamivudine-resistant strains in patients in Japan with acute hepatitis B. One hundred twenty-three patients with acute hepatitis B and 123 with chronic hepatitis B were studied. HBV subgenotypes and lamivudine-resistance mutations were determined by direct sequencing of the preS and polymerase region, respectively. HBV subgenotypes Aa (n=3), Ae (n=23), Ba (n=7), Bj (n=3), Cs (n=7), Ce (n=76), D (n=2), and H (n=2) were detected in patients with acute hepatitis. In patients with chronic hepatitis, HBV subgenotypes Ae (n=4), Ba (n=1), Bj (n=18), and Ce (n=100) were found. Non-common Japanese subgenotypes, that is, non-Bj and non-Ce, were detected more frequently in patients with acute hepatitis (35.8%) than in patients with chronic hepatitis (4.1%) (Odds ratio, 0.076; 95%CI, 0.029-0.200; P<0.0001). Lamivudine-resistance mutations were detected in chronic hepatitis patients with breakthrough hepatitis but not in other patients. In conclusion, the prevalence of uncommon Japanese HBV subgenotypes is expected to increase, although lamivudine-resistant strains have not yet been found in patients with acute hepatitis B. 相似文献